WORLD KINECT chair sells 20K shares under 10b5-1
WORLD KINECT CORP Executive Chairman Michael J. Kasbar reported selling a total of 20,000 shares of common stock in open-market transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
WORLD KINECT CORP Executive Chairman Michael J. Kasbar reported selling a total of 20,000 shares of common stock in open-market transactions. He sold 700 shares at $30.00 on June 5, 2026 and 19,300 shares at a weighted average price of $30.1747 on June 8, 2026.
After these sales, Kasbar directly holds 1,021,450 shares of WORLD KINECT CORP common stock. The filing notes that the sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on November 24, 2025, indicating they were scheduled in advance rather than timed opportunistically.
Insights
Kasbar’s 20,000-share sale is a pre-planned, routine disposition relative to his remaining stake.
Michael J. Kasbar, Executive Chairman of WORLD KINECT CORP, sold 20,000 common shares via open-market trades at prices around $30 in early June 2026. The transactions were executed under a Rule 10b5-1 trading plan adopted on November 24, 2025, meaning the sale schedule was set in advance.
Following these trades, he still directly owns 1,021,450 shares, so the disposition represents only a small portion of his reported holdings. Because the transactions are both pre-planned and modest relative to his remaining position, they generally signal routine portfolio management rather than a major shift in insider sentiment.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 19,300 | $30.1747 | $582K |
| Sale | Common Stock | 700 | $30.00 | $21K |
Footnotes (2)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on November 24, 2025.
- F2. The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $30.00 to $30.33, inclusive. The reporting person undertakes to provide the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each separate price within the specified range.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
weighted average sale price financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did WORLD KINECT CORP (WKC) Executive Chairman Michael Kasbar report in this Form 4?
Were Michael Kasbar’s WORLD KINECT CORP (WKC) stock sales under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.